CSF2, colony stimulating factor 2, 1437

N. diseases: 1028; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4551583
Disease: Cerebral cortical atrophy
Cerebral cortical atrophy
0.030 Biomarker disease BEFREE Here, we aim to forecast longitudinal magnetic resonance imaging (MRI)-driven cortical atrophy and clinical disability from cerebrospinal fluid (CSF) markers. 29226779 2019
CUI: C4551583
Disease: Cerebral cortical atrophy
Cerebral cortical atrophy
0.030 Biomarker disease BEFREE In all Alzheimer's disease dementia datasets we consistently identified four atrophy subtypes: (i) medial-temporal predominant atrophy with worst memory and language function, older age, lowest CSF tau levels and highest amount of vascular lesions; (ii) parieto-occipital atrophy with poor executive/attention and visuospatial functioning and high CSF tau; (iii) mild atrophy with best cognitive performance, young age, but highest CSF tau levels; and (iv) diffuse cortical atrophy with intermediate clinical, cognitive and biological features. 30351346 2018
CUI: C4551583
Disease: Cerebral cortical atrophy
Cerebral cortical atrophy
0.030 Biomarker disease BEFREE We also analyzed the correlation between baseline CSF biomarkers and cortical atrophy rates. 27693189 2017